MUSC Health acquires South Carolina's largest multispecialty practice for $111M / Fierce
fiercehealthcare - The deal, effective March 3, includes 126 physicians and advanced practitioners, expanding the academic system's primary care capacity.
#healthcare #mergersandacquisitions #corporatetakeover #hospitaloperations #healthcarefinance
Monday, March 9, 2026, 12:22 am / permalink 20353 / 4 stories in 2 days
Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma / MedCity
Frank Vinluan / medcitynews - Day One Biopharmaceuticals is Servier’s biggest acquisition yet, topping the $2.4 billion it paid to buy Shire’s cancer business in 2018. Day One markets Ojemda, approved for treating pediatric low-grade glioma, the most common type of brain cancer in chi…
#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment #oncology #healthcarefinance
Saturday, March 7, 2026, 12:22 am / permalink 20306 / 4 stories in 4 days
Novartis closes Avidity deal as rare heart disease spinout launches / Endpoints
Lei Lei Wu / endpoints - Atrium Therapeutics launched Friday morning as Novartis closed the $12 billion deal to buy Avidity Biosciences and its RNA muscle therapies. The spinout will take on Avidity’s early-stage programs for genetic cardiomyopathies — heart muscle diseases ...
#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #healthcarefinance
Monday, March 2, 2026, 12:23 am / permalink 19968 / 2 stories in 9 days
Gilead to acquire cell therapy manufacturer for $7.8B / Beckers
Paige Twenter / beckershospitalreview - In a deal worth $7.8 billion, Gilead Sciences has entered a definitive agreement to acquire Arcellx, a biotech company developing a cell therapy for multiple myeloma. Gilead announced the acquisition agreement a few months after Arcellx published positive…
#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #fda #oncology
Monday, February 23, 2026, 4:23 pm / permalink 19605 / 7 stories in 15 days
Novartis signs macrocyclic deal with Unnatural Products for $100M upfront / Endpoints
Kyle LaHucik / endpoints - Novartis will pay $100 million upfront to tap into a macrocyclic peptide platform from Unnatural Products, a deal that could lead to new cardiovascular disease medicines. The move allows the Swiss pharma giant to delve ...
#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment
Saturday, February 21, 2026, 6:22 am / permalink 19517 / 2 stories in 18 days
Hims to buy Australia’s Eucalyptus for $240M upfront in global push / Endpoints
Ngai Yeung / endpoints - In a bid to build out its global presence, Hims is buying Australian digital health company Eucalyptus in a deal worth $240 million upfront. The deal announced Thursday morning would allow Hims to launch in ...
#healthcare #mergersandacquisitions #corporatetakeover #digitalhealth
Saturday, February 21, 2026, 1:23 am / permalink 19510 / 5 stories in 18 days
Prime Healthcare Foundation acquires Maine health system / Healthcare Dive
Sydney Halleman / healthcaredive - Nonprofit Prime Foundation, an affiliate of for-profit hospital operator Prime Healthcare, now owns 21 hospitals across eight states.
#healthcare #mergersandacquisitions #corporatetakeover
Saturday, February 21, 2026, 12:23 am / permalink 19504 / 3 stories in 18 days
Walgreens to lay off hundreds of employees / Healthcare Dive
Dani James / healthcaredive - The drugstore retailer said it was simplifying its organization to speed up decision-making in a move impacting at least 600 workers.
#healthcare #pharmaceuticals #mergersandacquisitions
Saturday, February 21, 2026, 12:23 am / permalink 19503 / 2 stories in 18 days
Federal judge vacates FTC's expanded premerger notification requirements / Fierce
fiercehealthcare - The overhaul to the Hart-Scott-Rodino form went into effect in early 2025, and by the regulator's own estimates expanded merging companies' average paperwork burdens from 37 hours to 105 hours. The court's ordered rollback is set to take effect Feb. 19 pe…
#governmentpolicy #mergersandacquisitions #corporatetakeover
Monday, February 16, 2026, 12:21 am / permalink 19223 / 4 stories in 23 days
Eli Lilly Expands Its In Vivo Ambitions, Acquiring Cell Therapy Startup Orna for up to $2.4B / MedCity
Frank Vinluan / medcitynews - Orna Therapeutics brings Eli Lilly an in vivo cell therapy ready for Phase 1 testing as a potential treatment for autoimmune diseases. Lilly is now the latest pharma company to use M&A to enter this growing field, following deals made in the past year by …
#healthcare #pharmaceuticals #elililly #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment
Saturday, February 14, 2026, 3:21 am / permalink 19178 / 9 stories in 25 days
‘Vertical integration is destroying people’s ability to access care’: Payer CEOs face bipartisan congressional grilling / Beckers
Jakob Emerson / beckershospitalreview - The CEOs of the nation’s largest health insurers drew the ire of lawmakers on both sides of the aisle during congressional hearings Jan. 22 over industry consolidation, prior authorization practices and executive pay, with members pressing executives to e…
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #mergersandacquisitions #corporatetakeover
Thursday, January 22, 2026, 9:22 pm / permalink 18314 / 27 stories in 6 wks
CHS signs $450M hospital sale to Huntsville Hospital Health System / Fierce
fiercehealthcare - The deal for 180-bed Crestwood Medical Center, set to close in Q2, will add a fifteenth hospital to the northern Alabama-based nonprofit system.
#healthcare #mergersandacquisitions #corporatetakeover
Wednesday, January 21, 2026, 1:22 pm / permalink 18249 / 10 stories in 6 wks
Merck Could Strike 30 Billion Deal for Revolution Medicines / OncoDaily
oncodaily - According to the Financial Times, Merck is in talks to acquire Revolution Medicines, a Redwood City, California-based cancer drug developer, in a deal that could value the company at roughly […]
#healthcare #pharmaceuticals #publichealth #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment
Monday, January 12, 2026, 1:21 am / permalink 17767 / 2 stories in 1 month
New Jersey system to join RWJBarnabas / Beckers
Kristin Kuchno / beckershospitalreview - West Orange, N.J.-based RWJBarnabas Health and Englewood (N.J.) Health have signed a definitive agreement under which Englewood would become part of RWJBarnabas Health. The transaction is subject to state and federal regulatory approvals, according to a J…
#healthcare #publichealth #governmentpolicy #mergersandacquisitions #corporatetakeover
Saturday, January 10, 2026, 5:21 pm / permalink 17747 / 2 stories in 2 months
Maimonides Health to merge with NYC Health + Hospitals supported by $2.2B state grant / Fierce
fiercehealthcare - Brooklyn, New York-based Maimonides Health is merging with New York City's public health system NYC Health + Hospitals, the organizations announced Monday.
#healthcare #publichealth #governmentpolicy #mergersandacquisitions
Saturday, January 3, 2026, 7:22 am / permalink 17452 / 2 stories in 2 months
AstraZeneca bets up to $2B on Jacobio’s pan-KRAS inhibitor for cancer / Endpoints
Ayisha Sharma / endpoints - AstraZeneca is spending $100 million upfront to secure ex-China rights for an early-stage cancer drug developed by Jacobio Pharma. The UK drugmaker will be responsible for advancing and selling the oral pan-KRAS inhibitor, JAB-23E73, in ...
#pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment
Saturday, December 27, 2025, 6:20 am / permalink 17306 / 7 stories in 2 months
Sanofi buys hepatitis B vaccine maker Dynavax for $2.2B; gets CRL for MS drug / Endpoints
Elizabeth Cairns / endpoints - Sanofi is set to supplement its vaccine offering with the acquisition of Dynavax Technologies for $2.2 billion in cash, the companies said Wednesday. Separately, Sanofi said the ...
#healthcare #pharmaceuticals #publichealth #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #vaccinesafety
Saturday, December 27, 2025, 2:21 am / permalink 17302 / 3 stories in 2 months
ChristianaCare, Virtua Health call off $6.3B merger plans / Fierce
fiercehealthcare - ChristianaCare and Virtua Health have pulled the plug on their merger plans, jettisoning a deal that would have created a health system with a combined $6.3 billion in annual revenue.
#healthcare #mergersandacquisitions
Saturday, December 20, 2025, 12:21 am / permalink 17156 / 4 stories in 2 months
Mikael Dolsten removes himself from board candidacy at Novo; Bavarian Nordic chairman resigns / Endpoints
Alex Hoffman / endpoints - → In what appears to be another blow to Novo Nordisk, ex-Pfizer CSO Mikael Dolsten has withdrawn his nomination to join the company's board of directors due to ...
#healthcare #pharmaceuticals #publichealth #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment
Saturday, November 15, 2025, 3:21 pm / permalink 16003 / 2 stories in 3 months
Pfizer’s Sweeter $10B Offer Beats Novo Nordisk in Bidding War for Obesity Biotech Metsera / MedCity
Frank Vinluan / medcitynews - Pfizer’s offer of up to $86.25 in cash for each share of obesity drugs developer Metsera share tops the up to $86.20 Novo Nordisk was willing to pay. The financial consideration and the greater certainly of a deal close tipped the balance in Pfizer’s favo…
#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #pfizer #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment
Monday, November 10, 2025, 12:21 am / permalink 15823 / 4 stories in 4 months